Skip to main content
OpenTrials

Clinical trial condition

Non Hodgkin Lymphoma

Explore clinical trials studying Non Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

100 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Non Hodgkin Lymphoma trial results

Not Yet Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors

NCT03935282

Conditions
Behavior, Breast Diseases, Breast Neoplasm, +42 more
Locations
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa, United States
  • Saint Louis Cancer and Breast Institute-Ballwin Ballwin, Missouri, United States
  • Mercy Hospital Springfield Springfield, Missouri, United States
View Trial Details
Completed

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

NCT04673617

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Artiva Clinical Trial Site Birmingham, Alabama, United States
  • Artiva Clinical Trial Site Tucson, Arizona, United States
  • Artiva Clinical Trial Site Orange, California, United States
  • Artiva Clinical Trial Site San Diego, California, United States
View all 21 locations
View Trial Details

Related conditions